Vanguard Group’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $12.9B | Buy |
|
|||||
|
2025
Q1 | $13.3B | Buy |
|
|||||
|
2024
Q4 | $13.8B | Buy |
|
|||||
|
2024
Q3 | $14.9B | Buy |
|
|||||
|
2024
Q2 | $14.3B | Buy |
|
|||||
|
2024
Q1 | $14.1B | Buy |
|
|||||
|
2023
Q4 | $14.6B | Sell |
|
|||||
|
2023
Q3 | $16.8B | Sell |
|
|||||
|
2023
Q2 | $18.6B | Sell |
|
|||||
|
2023
Q1 | $20.7B | Buy |
|
|||||
|
2022
Q4 | $25.7B | Buy |
|
|||||
|
2022
Q3 | $21.6B | Buy |
|
|||||
|
2022
Q2 | $25.6B | Buy |
|
|||||
|
2022
Q1 | $24.8B | Buy |
|
|||||
|
2021
Q4 | $27.5B | Buy |
|
|||||
|
2021
Q3 | $19.8B | Buy |
|
|||||
|
2021
Q2 | $17.9B | Buy |
|
|||||
|
2021
Q1 | $16.3B | Buy |
|
|||||
|
2020
Q4 | $16.5B | Sell |
|
|||||
|
2020
Q3 | $16.6B | Sell |
|
|||||
|
2020
Q2 | $14.9B | Sell |
|
|||||
|
2020
Q1 | $15.1B | Buy |
|
|||||
|
2019
Q4 | $17.6B | Buy |
|
|||||
|
2019
Q3 | $16B | Buy |
|
|||||
|
2019
Q2 | $19.3B | Sell |
|
|||||
|
2019
Q1 | $19.1B | Sell |
|
|||||
|
2018
Q4 | $19.7B | Buy |
|
|||||
|
2018
Q3 | $19.5B | Buy |
|
|||||
|
2018
Q2 | $15.8B | Sell |
|
|||||
|
2018
Q1 | $15.6B | Buy |
|
|||||
|
2017
Q4 | $15.7B | Buy |
|
|||||
|
2017
Q3 | $15.2B | Buy |
|
|||||
|
2017
Q2 | $14.1B | Buy |
|
|||||
|
2017
Q1 | $14B | Buy |
|
|||||
|
2016
Q4 | $13.1B | Buy |
|
|||||
|
2016
Q3 | $13.3B | Buy |
|
|||||
|
2016
Q2 | $13.5B | Buy |
|
|||||
|
2016
Q1 | $11.2B | Buy |
|
|||||
|
2015
Q4 | $11.9B | Buy |
|
|||||
|
2015
Q3 | $11.3B | Buy |
|
|||||
|
2015
Q2 | $11.9B | Buy |
|
|||||
|
2015
Q1 | $12.3B | Buy |
|
|||||
|
2014
Q4 | $10.7B | Buy |
|
|||||
|
2014
Q3 | $9.88B | Buy |
|
|||||
|
2014
Q2 | $9.73B | Buy |
|
|||||
|
2014
Q1 | $10.4B | Buy |
|
|||||
|
2013
Q4 | $9.78B | Sell |
|
|||||
|
2013
Q3 | $9.23B | Buy |
|
|||||
|
2013
Q2 | $8.9B | Buy |
|